Sourasky Medical Center — Tel Aviv

Public research footprint of Sourasky Medical Center, compiled from the ClinicalTrials.gov public registry.

1,337

Registered studies

420

Active

203

Recruiting now

539

Completed

146

Stopped or withdrawn

Most-studied conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Head and Neck Squamous Cell Carcinoma (HNSCC) · Metastatic Pancreatic Ductal Adenocarcinoma · Pancreatic Ductal Adenocarcinoma (PDAC)

Recently updated registry entries

NCT05171647 — A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… (Active Not Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT06153966 — PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sourasky Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.